Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.44 |
| ▸ | APLNR | P35414 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 9/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 9/20 | 0.42 |
| ▸ | TSHR | P16473 | 9/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 9/20 | 0.42 |
| ▸ | LMNA | P02545 | 5/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | USP2 | O75604 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4119081 | 0.91 | TAS1R3 (0.45) | TAS1R3TAS1R1APLNRCYP1A2CYP3A4 | |
| SCHEMBL4130386 | 0.90 | TAS1R3 (0.44) | TAS1R3TAS1R1APLNRCYP1A2CYP3A4 | |
| SCHEMBL13776420 | 0.90 | L3MBTL1 (0.39) | CYP3A4TSHRCYP2C19LMNAHSD17B10 | |
| SCHEMBL4116863 | 0.89 | TAS1R3 (0.44) | TAS1R3TAS1R1APLNRCYP1A2CYP3A4 | |
| SCHEMBL4114269 | 0.89 | TAS1R3 (0.44) | TAS1R3TAS1R1APLNRCYP1A2CYP3A4 | |
| SCHEMBL4127861 | 0.89 | TAS1R3 (0.44) | TAS1R3TAS1R1APLNRCYP1A2CYP3A4 | |
| SCHEMBL4118899 | 0.88 | TAS1R3 (0.42) | TAS1R3TAS1R1APLNRCYP1A2CYP3A4 | |
| SCHEMBL4117312 | 0.84 | MAPT (0.42) | TAS1R3TAS1R1APLNRCYP1A2CYP3A4 | |
| SCHEMBL14146192 | 0.83 | GAA (0.38) | TAS1R3TAS1R1CYP3A4CYP2C19LMNA | |
| SCHEMBL4120083 | 0.82 | TSHR (0.43) | TAS1R3TAS1R1APLNRCYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090181942-A1 | TRICYCLIC COMPOUNDS | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-07-16 | — | — | US | disclosed |
| US-20090181942-A1 | TRICYCLIC COMPOUNDS | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-07-16 | — | — | US | disclosed |
| EP-1939205-A1 | TRICYCLIC COMPOUND | Daiichi Sankyo Company, Limited (JP) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181942-A1 | TRICYCLIC COMPOUNDS | FDFT1, COASY, HMGCR | TAS1R3 3354/4885TAS1R1 2624/4885APLNR 795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.